BioChain announces expanded line of NGS characterized bio-samples for oncology researchers
NEWARK, Calif., Sept. 22, 2021 /PRNewswire/ — BioChain Institute, (“BioChain”), a leader in high quality processed bio-sample products, announced an expanded line of Next Generation Sequencing (NGS) characterized bio-samples encompassing a variety of cancer-related mutations available…
Comments Off on BioChain announces expanded line of NGS characterized bio-samples for oncology researchers